Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclodextrin-modified polyethylenimine polymers for gene delivery.

Suzie H Pun1, Nathalie C Bellocq, Aijie Liu

  • 1Insert Therapeutics Inc., 2585 Nina Street, Pasadena, California 91107, USA.

Bioconjugate Chemistry
|July 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transitive reasoning as linear classification.

bioRxiv : the preprint server for biology·2026
Same author

Aging macaques bridge the translational gap in perivascular space biology.

Scientific reports·2026
Same author

Genetic testing and analysis of 1024 children with global developmental delay or intellectual disability: a single-center cohort study.

European journal of pediatrics·2026
Same author

The Janus Effect of Bilirubin After Liver Transplantation: A Retrospective Study of Phase-Dependent Risk and Protection Against Chronic Kidney Disease.

Nephrology (Carlton, Vic.)·2026
Same author

Time-dependent changes in stepping performance and velocity following partial dopaminergic lesions in the SNc of male and female rats.

PloS one·2026
Same author

Discovery and Cryo-EM-Guided Development of a Neuropilin-2-Binding Aptamer for Receptor Antagonism.

Journal of the American Chemical Society·2026

Cyclodextrin-grafted polyethylenimines show promise as nonviral gene delivery agents. These modified polymers exhibit low toxicity and effective gene expression in vitro and in vivo, particularly in liver tissue.

Area of Science:

  • Biomaterials Science
  • Gene Therapy
  • Polymer Chemistry

Background:

  • Nonviral gene delivery vectors are crucial for therapeutic applications.
  • Polyethylenimines (PEI) are effective gene carriers but exhibit toxicity.
  • Modifying PEI with cyclodextrin (CD) aims to improve safety and efficacy.

Purpose of the Study:

  • To synthesize and characterize linear and branched poly(ethylenimines) grafted with beta-cyclodextrin (CD-lPEI and CD-bPEI).
  • To evaluate the in vitro and in vivo performance of these novel nonviral gene delivery agents.
  • To investigate the impact of cyclodextrin grafting levels on toxicity and transfection efficiency.

Main Methods:

  • Preparation of CD-lPEI and CD-bPEI via grafting.
  • Assessment of in vitro toxicity and transfection efficiency.

Related Experiment Videos

  • Formulation of gene delivery particles with adamantane-poly(ethylene glycol) (AD-PEG) conjugates.
  • Evaluation of in vivo gene delivery in mice via tail vein injection.

    • Main Results:

    • In vitro toxicity and transfection efficiency were dependent on the degree of cyclodextrin grafting.
    • CD-PEI/AD-PEG complexes formed stable particles at physiological salt concentrations.
    • PEGylated CD-lPEI particles achieved gene expression comparable to or exceeding unmodified lPEI.
    • In vivo studies in mice showed no observable toxicity and successful gene delivery to the liver.

    Conclusions:

    • Cyclodextrin grafting is a viable strategy to enhance the safety and efficacy of polyethylenimine-based gene vectors.
    • CD-lPEI, particularly when PEGylated, represents a promising nonviral gene delivery agent for in vitro and in vivo applications.
    • Further research into optimizing CD-PEI formulations could lead to advanced gene therapy strategies.